Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Zinc finger protein 877, pseudogene (ZNF877P)** is classified as a pseudogene in the human genome. While zinc finger proteins in general are a large family of proteins featuring C2H2-type motifs often functioning as DNA-binding transcription factors[4][7], the ZNF877P gene is annotated as a pseudogene and is not known to produce a functional protein product[2]. As such, it is not considered a therapeutic target, does not have established biological functions, disease roles, or drug interactions, and is not classified in standard molecular target families such as receptor, enzyme, or transporter. Pseudogenes like ZNF877P are non-coding gene relics that arise from gene duplication or retrotransposition events[12]. Some pseudogenes can have regulatory roles, though no such functions are currently attributed to ZNF877P based on available data[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 877, pseudogene (ZNF877P).